For the quarter ending 2026-03-31, TNXP has $257,912K in assets. $30,775K in debts. $185,470K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 185,470 | 207,637 | 190,055 | |
| Accounts receivable, net | 8,820 | 6,271 | 3,481 | |
| Inventory | 3,645 | 6,013 | 5,729 | |
| Prepaid expenses and other current assets | 9,233 | 8,955 | 8,806 | |
| Total current assets | 207,168 | 228,876 | 208,071 | |
| Property and equipment gross | 51,471 | 50,478 | 48,108 | |
| Less accumulated depreciation and amortization | 6,577 | 6,022 | 5,534 | |
| Property and equipment, net | 44,894 | 44,456 | 42,574 | |
| Intangible assets, net | 120 | 120 | 120 | |
| Operating lease right-to-use assets | 1,445 | 1,544 | 376 | |
| Other non-current assets | 4,285 | 2,175 | 1,299 | |
| Total assets | 257,912 | 277,171 | 252,440 | |
| Accounts payable | 9,649 | 8,114 | 8,540 | |
| Accrued expenses and other current liabilities | 19,836 | 22,598 | 12,332 | |
| Lease liability, short term | 162 | 125 | 159 | |
| Total current liabilities | 29,647 | 30,837 | 21,031 | |
| Lease liability, long term | 1,128 | 1,184 | 266 | |
| Total liabilities | 30,775 | 32,021 | 21,297 | |
| Common stock, 0.001 par value 1,000,000,000 shares authorized 14,205,401 and 12,788,069 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively and 5,883 shares to be issued as of december 31, 2025 | 14 | 13 | 10 | |
| Additional paid in capital | 1,122,315 | 1,100,141 | 1,039,212 | |
| Accumulated deficit | -894,909 | -854,715 | -807,805 | |
| Accumulated other comprehensive loss | -283 | -289 | -274 | |
| Total stockholders equity | 227,137 | 245,150 | 231,143 | |
| Total liabilities and stockholders equity | 257,912 | 277,171 | 252,440 | |
Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. (TNXP)